Mainstreamed genetic testing of breast cancer patients in two hospitals in South Eastern Norway
出版年份 2020 全文链接
标题
Mainstreamed genetic testing of breast cancer patients in two hospitals in South Eastern Norway
作者
关键词
-
出版物
Familial Cancer
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-01-30
DOI
10.1007/s10689-020-00160-x
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Identification of germline pathogenic variants in DNA damage repair genes by a next-generation sequencing multigene panel in BRCAX patients
- (2019) Marta Rodríguez-Balada et al. CLINICAL BIOCHEMISTRY
- Mainstreamed genetic testing for women with ovarian cancer: first-year experience
- (2018) Belinda Rahman et al. JOURNAL OF MEDICAL GENETICS
- Gene panel testing of 5589 BRCA1/2 -negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer
- (2018) Jan Hauke et al. Cancer Medicine
- A contemporary review of male breast cancer: current evidence and unanswered questions
- (2018) Roberto A. Leon-Ferre et al. CANCER AND METASTASIS REVIEWS
- Multigene panel testing beyond BRCA1/2 in breast/ovarian cancer Spanish families and clinical actionability of findings
- (2018) Sandra Bonache et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Efficacy versus effectiveness of clinical genetic testing criteria for BRCA1 and BRCA2 hereditary mutations in incident breast cancer
- (2017) Martin P. Nilsson et al. Familial Cancer
- Trends in utilization and costs of BRCA testing among women aged 18–64 years in the United States, 2003–2014
- (2017) Zhuo Chen et al. GENETICS IN MEDICINE
- Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer
- (2017) Allison W. Kurian et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
- (2017) Karoline B. Kuchenbaecker et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer
- (2017) Christopher P. Childers et al. JOURNAL OF CLINICAL ONCOLOGY
- Genetic Testing: What Problem Are We Trying to Solve?
- (2017) Kevin S. Hughes JOURNAL OF CLINICAL ONCOLOGY
- Phase I Study of Veliparib (ABT-888) Combined with Cisplatin and Vinorelbine in Advanced Triple-Negative Breast Cancer and/or BRCA Mutation-Associated Breast Cancer
- (2016) E. T. Rodler et al. CLINICAL CANCER RESEARCH
- BRCA testing within the Department of Veterans Affairs: concordance with clinical practice guidelines
- (2016) Danielle S. Chun et al. Familial Cancer
- Tailoring adjuvant chemotherapy regimens for patients with triple negative breast cancer
- (2015) Daniel G. Stover et al. BREAST
- BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study
- (2015) Hildegunn Høberg-Vetti et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals
- (2015) Terri Febbraro et al. GYNECOLOGIC ONCOLOGY
- Characteristics associated with genetic counseling referral and BRCA1/2 testing among women in a large integrated health system
- (2014) Cecelia A. Bellcross et al. GENETICS IN MEDICINE
- Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis
- (2014) K. Metcalfe et al. BMJ-British Medical Journal
- Prevalence and Healthcare Actions of Women in a Large Health System with a Family History Meeting the 2005 USPSTF Recommendation for BRCA Genetic Counseling Referral
- (2013) C. A. Bellcross et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Does the Diagnosis of Breast or Ovarian Cancer Trigger Referral to Genetic Counseling?
- (2013) C. Bethan Powell et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial
- (2013) Shahneen K Sandhu et al. LANCET ONCOLOGY
- Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality
- (2010) Susan M. Domchek JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
- (2010) Andrew Tutt et al. LANCET
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk reducing mastectomy: outcomes in 10 European centres
- (2008) D G R Evans et al. JOURNAL OF MEDICAL GENETICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started